Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
2976
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $7.65M | ﹤0.01% |
393,549
+240,445
| +157% | +$5.7M |
|
|
BAND
2977
Bandwidth Inc
BAND
$1.74B
| $7.64M | ﹤0.01% |
558,642
+27,616
| +5% | +$348K |
|
2978
CALL
Arthur J. Gallagher & Co
AJG
$64.4B
| $7.64M | ﹤0.01% |
34,800
-8,000
| -19% | -$1.66M |
|
2979
iShares Core S&P Mid-Cap ETF
IJH
$129B
| $7.63M | ﹤0.01% |
145,860
+132,245
| +971% | +$6.57M |
|
2980
Community Bank
CBU
$3.46B
| $7.63M | ﹤0.01% |
162,652
-31,093
| -16% | -$1.52M |
|
2981
iShares International Select Dividend ETF
IDV
$8.59B
| $7.62M | ﹤0.01% |
289,491
+177,891
| +159% | +$4.85M |
|
|
KALV
2982
DELISTED
KalVista Pharmaceuticals
KALV
| $7.62M | ﹤0.01% |
846,606
+718,211
| +559% | +$6.62M |
|
|
AZUL
2983
DELISTED
Azul
AZUL
| $7.62M | ﹤0.01% |
556,432
-963,923
| -63% | -$8.77M |
|
2984
Methode Electronics
MEI
$608M
| $7.61M | ﹤0.01% |
226,972
+186,100
| +455% | +$7.59M |
|
2985
Brighthouse Financial
BHF
$3.37B
| $7.6M | ﹤0.01% |
160,430
+43,048
| +37% | +$1.85M |
|
|
GAP
2986
CALL
The Gap Inc
GAP
$7.42B
| $7.58M | ﹤0.01% |
849,100
+503,600
| +146% | +$4.49M |
|
|
SCPL
2987
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $7.57M | ﹤0.01% |
384,649
-267,409
| -41% | -$4.86M |
|
2988
DigitalBridge
DBRG
$2.94B
| $7.56M | ﹤0.01% |
514,044
-2,263,985
| -81% | -$27.8M |
|
2989
CALL
Teva Pharmaceuticals
TEVA
$42.8B
| $7.56M | ﹤0.01% |
1,003,500
+394,000
| +65% | +$3.19M |
|
2990
CALL
Leidos
LDOS
$18B
| $7.56M | ﹤0.01% |
85,400
+44,500
| +109% | +$3.79M |
|
2991
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $7.54M | ﹤0.01% |
74,800
-1,300
| -2% | -$131K |
|
2992
CALL
AerCap
AER
$24B
| $7.54M | ﹤0.01% |
118,700
-52,500
| -31% | -$3.03M |
|
2993
CALL
Azenta
AZTA
$1.46B
| $7.53M | ﹤0.01% |
161,300
+26,600
| +20% | +$1.16M |
|
2994
PUT
Sinclair Inc
SBGI
$1.07B
| $7.53M | ﹤0.01% |
544,700
+510,700
| +1,502% | +$8.43M |
|
2995
Telephone and Data Systems
TDS
$4.05B
| $7.53M | ﹤0.01% |
914,516
-86,978
| -9% | -$738K |
|
|
FYBR
2996
DELISTED
Frontier Communications
FYBR
| $7.52M | ﹤0.01% |
+403,467
| New | +$7.57M |
|
2997
CALL
Teradata
TDC
$2.57B
| $7.52M | ﹤0.01% |
140,800
+20,500
| +17% | +$924K |
|
2998
uniQure
QURE
$3.37B
| $7.52M | ﹤0.01% |
656,138
+313,773
| +92% | +$5.94M |
|
2999
Kornit Digital
KRNT
$775M
| $7.51M | ﹤0.01% |
255,674
-114,135
| -31% | -$2.58M |
|
3000
PUT
Levi Strauss
LEVI
$8.68B
| $7.51M | ﹤0.01% |
520,200
+180,900
| +53% | +$2.61M |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.